Showing results (191-200 of 202) with videos related to

Sort By:
Pageof 21
AJR. American Journal of Roentgenology|November 13, 2019
Traditional Serrated Adenomas on CT Colonography: International Multicenter Experience With This Rare Colorectal NeoplasmJeannine A Ruby, Laura Pusceddu, Andrew A Plumb, et al.
Biomedicines|January 21, 2022
Large-Scale Functional Genomics Screen to Identify Modulators of Human β-Cell Insulin SecretionIwona Szczerbinska, Annamaria Tessitore, Lena Kristina Hansson, et al.
Molecular Metabolism|March 16, 2016
Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patientsHenriette Kirchner, Indranil Sinha, Hui Gao, et al.
Cell Reports|January 19, 2017
Human Carboxylesterase 2 Reverses Obesity-Induced Diacylglycerol Accumulation and Glucose IntoleranceMaxwell A Ruby, Julie Massart, Devon M Hunerdosse, et al.
Annals of Surgery|November 17, 2012
Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapyJames D Smith, Jeannine A Ruby, Karyn A Goodman, et al.
Inflammopharmacology|October 30, 2025
Modulatory effects of bioactive natural compounds on pruritic pathways: mechanistic basis and therapeutic prospectsWagih H Marcus, Hassan A Ruby, Amira E Awwad, et al.
European Journal of Pharmacology|July 25, 2025
Repositioning of a nutraceutical, scoparone, in the management of MK-801-induced schizophrenia-like behavior in Mice: An insight into SIRT1/PGC-1α/TFAM pathwayMostafa A Rabie, Wagih H Marcus, Mohamed A Sadek, et al.
Metabolism: Clinical and Experimental|April 23, 2023
MLX plays a key role in lipid and glucose metabolism in humans: Evidence from in vitro and in vivo studiesShilpa R Nagarajan, Eilidh J Livingstone, Thomas Monfeuga, et al.
EJNMMI Research|June 5, 2013
Pilot study of PET imaging of 124I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal cancer and head and neck cancerJoseph A O'Donoghue, José G Guillem, Heiko Schöder, et al.
Annals of Surgery|November 29, 2012
Neither FDG-PET Nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective studyJosé G Guillem, Jeannine A Ruby, Tobias Leibold, et al.
Pageof 21